This analysis identifies lesion features affecting treatment duration in leishmaniasis, suggesting improved clinical strategies.
This study identifies distinct lesion features in MCL and underscores secondary infection as a key modifiable factor associated with prolonged therapy. These findings support the need for early recognition, infection control, and tailored clinical strategies to improve leishmaniasis outcomes in endemic settings.
No takes yet. Share an insight, caveat, or question.
Esen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: